Published in Respiratory Therapeutics Week, March 27th, 2006
According to recent research from New Zealand and Australia, "Influenza vaccinations are currently recommended in the care of people with COPD, but these recommendations are based largely on evidence from observational studies with very few randomized controlled trials (RCTs) reported. Influenza infection causes excess morbidity and mortality in COPD patients but there is also the potential for influenza vaccination to cause adverse effects or not to be cost effective. To evaluate the evidence from RCTs for a treatment effect of influenza vaccination in COPD...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week